Stem Cell Research and Regenerative Medicine

Bioequivalence High Impact Factor Journals

Bioequivalence may be a term in medicine accustomed assess the expected in vivo biological equivalence of two proprietary preparations of a drug. If a pair of merchandise unit same to be bioequivalent it suggests that they could be expected to be, for all intents and functions, the same.   Birkett (2003) made public bioequivalence by stating that, "two pharmaceutical merchandise unit bioequivalent if sq. measure|they're} pharmaceutically equivalent and their bioavailabilities (rate and extent of availability) once administration at intervals identical molar dose ar rather like such a degree that their effects, with respect to every effectivity and safety, could also be expected to be primarily an identical. Pharmaceutical equivalence implies an identical amount of an identical active substance(s), at intervals identical dose kind, for an identical route of administration and meeting identical or comparable standards.   For the earth Health Organization (WHO) "two pharmaceutical merchandise unit bioequivalent if they are pharmaceutically equivalent or pharmaceutical alternatives, and their bioavailabilities, in terms of rate (Cmax and tmax) and extent of absorption (area beneath the curve), once administration of an identical molar dose beneath an identical conditions, unit rather like such a degree that their effects could also be expected to be primarily the same".    

High Impact List of Articles

Relevant Topics in Material Science